ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,155Medicare Part D Prescriptions Filled, Including Refills

Rank: 74 out of 278

$451K Total Retail Price of All Prescriptions

Rank: 125 out of 278

460 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 460 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

20% of this provider’s 460 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 8,326 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
HYDROCODONE-ACETAMINOPHEN 463 353 S3 1 1
LISINOPRIL-HYDROCHLOROTHIAZIDE 390 321 2 31
OMEPRAZOLE 359 316 3 3
METFORMIN HCL 351 304 4 8
SIMVASTATIN 327 307 5 4
LISINOPRIL 273 217 6 5
AMLODIPINE BESYLATE 245 239 7 7
ZOLPIDEM TARTRATE 222 155 8 26
POTASSIUM CHLORIDE 206 188 9 17
LEVOTHYROXINE SODIUM 205 194 10 2
METOPROLOL TARTRATE 196 178 11 9
CARVEDILOL 190 162 12 23
FUROSEMIDE 171 142 13 6
SUBOXONE 168 0 14 157
CARISOPRODOL 153 77 R 15 158
MELOXICAM 141 125 16 37
AZITHROMYCIN 132 107 17 39
WARFARIN SODIUM 122 86 18 11
TAMSULOSIN HCL 121 106 19 32
CITALOPRAM HBR 120 104 20 21
TRAMADOL HCL 116 77 21 22
HYDROCHLOROTHIAZIDE 114 96 22 15
TRIAMTERENE-HCTZ 113 112 23 58
ISOSORBIDE MONONITRATE ER 105 98 24 33
SULFAMETHOXAZOLE-TRIMETHOPRIM 104 93 25 98
GABAPENTIN 95 77 26 12
BUMETANIDE 91 82 27 154
ATORVASTATIN CALCIUM 91 60 27 13
SERTRALINE HCL 89 84 29 25
NEXIUM 85 74 30 14
OXYCODONE-ACETAMINOPHEN 82 63 S2 31 71
SPIRONOLACTONE 82 79 31 62
ALLOPURINOL 80 79 33 38
CIPROFLOXACIN HCL 80 65 33 65
LOVASTATIN 78 76 35 52
GLIPIZIDE 74 49 36 55
GLIPIZIDE XL 69 59 37 160
CLOPIDOGREL 69 59 37 20
BYSTOLIC 65 53 39 114
DONEPEZIL HCL 65 65 39 29
ACTOS 62 51 41 101
TERAZOSIN HCL 58 47 42 151
MUPIROCIN 55 51 43 219
ALENDRONATE SODIUM 53 49 44 51
PROAIR HFA 52 39 45 34
MECLIZINE HCL 52 48 45 111
CEFADROXIL 51 47 47 352
PREDNISONE 51 46 47 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 16, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.